• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiple sclerosis in Isfahan, Iran: an update.

作者信息

Etemadifar Masoud, Abtahi Seyed-Hossein, Akbari Mojtaba, Murray Richard T, Ramagopalan Sreeram V, Fereidan-Esfahani Mahboobeh

机构信息

Department of Neurology, Isfahan University of Medical Sciences, Iran Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan University of Medical Sciences, Iran.

Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan University of Medical Sciences, Iran Medical Student's Research Center, Isfahan University of Medical Sciences, Iran.

出版信息

Mult Scler. 2014 Jul;20(8):1145-7. doi: 10.1177/1352458513516531. Epub 2013 Dec 10.

DOI:10.1177/1352458513516531
PMID:24326673
Abstract
摘要

相似文献

1
Multiple sclerosis in Isfahan, Iran: an update.伊朗伊斯法罕的多发性硬化症：最新情况
Mult Scler. 2014 Jul;20(8):1145-7. doi: 10.1177/1352458513516531. Epub 2013 Dec 10.
2
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症发病率和患病率急剧上升。
Mult Scler. 2011 Aug;17(8):1022-7. doi: 10.1177/1352458511401460. Epub 2011 Apr 1.
3
Multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕的多发性硬化症
Int Rev Neurobiol. 2007;79:357-75. doi: 10.1016/S0074-7742(07)79016-5.
4
Prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症的患病率。
Neuroepidemiology. 2006;27(1):39-44. doi: 10.1159/000094235. Epub 2006 Jun 27.
5
Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.儿童期起病的多发性硬化症：来自伊朗伊斯法罕的82例患者报告。
Arch Iran Med. 2007 Apr;10(2):152-6.
6
Multiple sclerosis among Afghan immigrants in Isfahan, Iran.伊朗伊斯法罕的阿富汗移民中的多发性硬化症。
Mult Scler Relat Disord. 2017 Apr;13:52-57. doi: 10.1016/j.msard.2017.02.006. Epub 2017 Feb 7.
7
Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis.伊朗德黑兰的多发性硬化症：连接点趋势分析
Mult Scler. 2014 Apr;20(4):512. doi: 10.1177/1352458513494496. Epub 2013 Jul 8.
8
Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.1996 年至 2021 年伊朗伊斯法罕多发性硬化症的患病率和发病率：一项基于人群的研究。
Mult Scler Relat Disord. 2024 Apr;84:105479. doi: 10.1016/j.msard.2024.105479. Epub 2024 Feb 1.
9
Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.伊朗多发性硬化症：8000 例患者的人口统计学研究及随时间的变化。
Eur Neurol. 2010;64(6):331-6. doi: 10.1159/000321649. Epub 2010 Nov 13.
10
The distinctive contrast of multiple sclerosis epidemiology between Persians and Armenian minority community of Isfahan city, Iran.
Neurol Sci. 2015 Apr;36(4):657-8. doi: 10.1007/s10072-014-2013-0. Epub 2015 Jan 11.

引用本文的文献

1
Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis.利妥昔单抗与那他珠单抗治疗复发缓解型多发性硬化症的成本效果分析。
BMC Health Serv Res. 2022 Jan 28;22(1):118. doi: 10.1186/s12913-022-07495-4.
2
Economic burden of multiple sclerosis: a cross-sectional study in Iran.多发性硬化症的经济负担：伊朗的一项横断面研究。
Health Econ Rev. 2022 Jan 3;12(1):2. doi: 10.1186/s13561-021-00350-y.
3
Multiple sclerosis in Iran: An epidemiological update with focus on air pollution debate.
伊朗的多发性硬化症：聚焦空气污染争议的流行病学最新情况
J Clin Transl Res. 2021 Feb 17;7(1):49-60. eCollection 2021 Feb 25.
4
Familial aggregation of multiple sclerosis: Results from the national registry of the disease in Saudi Arabia.多发性硬化症的家族聚集性：沙特阿拉伯全国性该疾病登记的结果。
Mult Scler J Exp Transl Clin. 2020 Oct 12;6(4):2055217320960499. doi: 10.1177/2055217320960499. eCollection 2020 Oct-Dec.
5
Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.伊朗多发性硬化症的流行病学：系统评价和荟萃分析。
PLoS One. 2019 Apr 9;14(4):e0214738. doi: 10.1371/journal.pone.0214738. eCollection 2019.
6
Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia.沙特阿拉伯某大学医院多发性硬化症的临床表现及表型谱
J Clin Neurol. 2018 Jul;14(3):359-365. doi: 10.3988/jcn.2018.14.3.359.
7
The Relationship Between Religious Beliefs and Quality of Life Among Patients With Multiple Sclerosis.多发性硬化症患者宗教信仰与生活质量的关系
J Relig Health. 2017 Oct;56(5):1826-1836. doi: 10.1007/s10943-017-0411-3.
8
Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province.评估伊斯法罕省患有多发性硬化症的育龄女性的多发性硬化症风险因素。
Int J Prev Med. 2016 Mar 10;7:58. doi: 10.4103/2008-7802.178532. eCollection 2016.
9
miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.miR-141和miR-200a：揭示Th17/Treg分化调控及多发性硬化症发病机制中新的潜在作用因子
PLoS One. 2015 May 4;10(5):e0124555. doi: 10.1371/journal.pone.0124555. eCollection 2015.
10
The distinctive contrast of multiple sclerosis epidemiology between Persians and Armenian minority community of Isfahan city, Iran.
Neurol Sci. 2015 Apr;36(4):657-8. doi: 10.1007/s10072-014-2013-0. Epub 2015 Jan 11.